---
figid: PMC5402749__nihms859483f1
figlink: /pmc/articles/PMC5402749/figure/F1/
number: Figure 1
caption: Tumor necrosis factor alpha (TNFα) ligation to tumor necrosis factor receptor
  1 (TNFR1) results in receptor-interacting serine/threonine-protein kinase 1 (RIPK1)
  mediated formation of complex-I, which is mediated by E3 ubiquitin ligases cellular
  inhibitor of apoptosis protein (cIAP1/2) (and/or X-linked inhibitor of apoptosis
  protein XIAP) and TNF receptor-associated factor 2 (TRAF2), as well as linear ubiquitination
  complex (LUBAC). Complex-I promotes survival and cytokine production via I-kappa-B-kinase
  (IKK)- and transforming growth factor-beta-activated kinase 1 (TAK1)-mediated nuclear
  factor kappa B (NF-κB) pathway activation. Apoptosis, RIPK1-dependent apoptosis
  (RDA) or necroptosis pathways may be activated to promote cell death following deubiquitination
  of RIPK1 by Cyld and/or A20. While canonical complex-IIa does not require RIPK1
  kinase activity, RDA complex-IIa and complex-IIb/necrosome require RIPK1 kinase
  activity (*), which is inhibited by Nec-1s. Caspase8-caspase3 pathway is activated
  downstream of both canonical and RDA complex-IIa to promote apoptotic cell death,
  while Mixed lineage kinase domain-like protein (MLKL) phosphorylation and oligomerization
  downstream of complex-IIb/necrosome to promotes necrotic cell death.
pmcid: PMC5402749
papertitle: Necroptosis and Cancer.
reftext: Ayaz Najafov, et al. Trends Cancer. 2017 Apr;3(4):294-301.
pmc_ranked_result_index: '80779'
pathway_score: 0.9324405
filename: nihms859483f1.jpg
figtitle: Necroptosis and Cancer
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5402749__nihms859483f1.html
  '@type': Dataset
  description: Tumor necrosis factor alpha (TNFα) ligation to tumor necrosis factor
    receptor 1 (TNFR1) results in receptor-interacting serine/threonine-protein kinase
    1 (RIPK1) mediated formation of complex-I, which is mediated by E3 ubiquitin ligases
    cellular inhibitor of apoptosis protein (cIAP1/2) (and/or X-linked inhibitor of
    apoptosis protein XIAP) and TNF receptor-associated factor 2 (TRAF2), as well
    as linear ubiquitination complex (LUBAC). Complex-I promotes survival and cytokine
    production via I-kappa-B-kinase (IKK)- and transforming growth factor-beta-activated
    kinase 1 (TAK1)-mediated nuclear factor kappa B (NF-κB) pathway activation. Apoptosis,
    RIPK1-dependent apoptosis (RDA) or necroptosis pathways may be activated to promote
    cell death following deubiquitination of RIPK1 by Cyld and/or A20. While canonical
    complex-IIa does not require RIPK1 kinase activity, RDA complex-IIa and complex-IIb/necrosome
    require RIPK1 kinase activity (*), which is inhibited by Nec-1s. Caspase8-caspase3
    pathway is activated downstream of both canonical and RDA complex-IIa to promote
    apoptotic cell death, while Mixed lineage kinase domain-like protein (MLKL) phosphorylation
    and oligomerization downstream of complex-IIb/necrosome to promotes necrotic cell
    death.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP7
  - BIRC3
  - CASP6
  - CASP9
  - CASP4
  - CASP5
  - CASP8
  - MLKL
  - IKBKG
  - NFKB1
  - IKBKB
  - TNFAIP3
  - CASP3
  - NR2C2
  - TNF
  - TNFRSF1A
  - TRAF2
  - CYLD
  - FADD
  - NFKB2
  - BIRC2
  - CASP2
  - CHUK
  - CASP12
  - CASP14
  - REL
  - RELA
  - RIPK1
  - RIPK3
  - DIABLO
  - RELB
  - TAB3
  - TAB2
  - CASP1
  - CASP10
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: CIAP1/2
  symbol: c-IAP2
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC3
  entrez: '330'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: MLKL
  symbol: MLKL
  source: hgnc_symbol
  hgnc_symbol: MLKL
  entrez: '197259'
- word: NEMO
  symbol: NEMO
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: IKKB
  symbol: IKK-beta
  source: hgnc_alias_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: byCyld/A20
  symbol: A20
  source: hgnc_alias_symbol
  hgnc_symbol: TNFAIP3
  entrez: '7128'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TNFR1
  symbol: TNFR1
  source: hgnc_prev_symbol
  hgnc_symbol: TNFRSF1A
  entrez: '7132'
- word: IKK..
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: TRAF2
  symbol: TRAF2
  source: hgnc_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: Cyld
  symbol: CYLD
  source: hgnc_symbol
  hgnc_symbol: CYLD
  entrez: '1540'
- word: FADD
  symbol: FADD
  source: hgnc_symbol
  hgnc_symbol: FADD
  entrez: '8772'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: CIAP1/2–
  symbol: c-IAP1
  source: hgnc_alias_symbol
  hgnc_symbol: BIRC2
  entrez: '329'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: IKK..
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: IKK..
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: RIPK1
  symbol: RIPK1
  source: hgnc_symbol
  hgnc_symbol: RIPK1
  entrez: '8737'
- word: RIPK3
  symbol: RIPK3
  source: hgnc_symbol
  hgnc_symbol: RIPK3
  entrez: '11035'
- word: Smac
  symbol: SMAC
  source: hgnc_alias_symbol
  hgnc_symbol: DIABLO
  entrez: '56616'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: TAB2/3
  symbol: TAB3
  source: hgnc_symbol
  hgnc_symbol: TAB3
  entrez: '257397'
- word: CASP8
  symbol: CASP8
  source: hgnc_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: TAB2/3
  symbol: TAB2
  source: hgnc_symbol
  hgnc_symbol: TAB2
  entrez: '23118'
- word: CASP3/7
  symbol: CASP7
  source: hgnc_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: CASP3/7
  symbol: CASP3
  source: hgnc_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
chemicals: []
diseases: []
---
